Possible Therapeutic Applications of Targeting STAP Proteins in Cancer

Biol Pharm Bull. 2021;44(12):1810-1818. doi: 10.1248/bpb.b21-00672.

Abstract

The signal-transducing adaptor protein (STAP) family, including STAP-1 and STAP-2, contributes to a variety of intracellular signaling pathways. The proteins in this family contain typical structures for adaptor proteins, such as Pleckstrin homology in the N-terminal regions and SRC homology 2 domains in the central regions. STAP proteins bind to inhibitor of kappaB kinase complex, breast tumor kinase, signal transducer and activator of transcription 3 (STAT3), and STAT5, during tumorigenesis and inflammatory/immune responses. STAP proteins positively or negatively regulate critical steps in intracellular signaling pathways through individually unique mechanisms. This article reviews the roles of the novel STAP family and the possible therapeutic applications of targeting STAP proteins in cancer.

Keywords: adaptor protein; cancer cell growth; signal transduction; signal-transducing adaptor protein (STAP); tumorigenesis.

Publication types

  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Animals
  • Blood Proteins / metabolism
  • Carcinogenesis / metabolism*
  • Humans
  • Neoplasm Proteins / metabolism
  • Neoplasms / metabolism*
  • Phosphoproteins / metabolism
  • Protein-Tyrosine Kinases / metabolism
  • STAT3 Transcription Factor / metabolism
  • STAT5 Transcription Factor / metabolism
  • Signal Transduction
  • Tumor Suppressor Proteins / metabolism
  • Tyrosine / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Blood Proteins
  • Neoplasm Proteins
  • Phosphoproteins
  • STAP1 protein, human
  • STAP2 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • STAT5 Transcription Factor
  • STAT5A protein, human
  • Tumor Suppressor Proteins
  • platelet protein P47
  • Tyrosine
  • Protein-Tyrosine Kinases
  • PTK6 protein, human